TRIM29 and nasopharyngeal carcinoma: Elevated TRIM29 expression is accompanied by more invasive phenotypes of malignancies, including bladder, cervical, colorectal, gastric, lung, ovarian, pancreatic, and thyroid cancers; osteosarcoma; and nasopharyngeal carcinoma (NPC).